Annals of Coloproctology

Original Articles

Benign bowel disease

Development of a home health care service platform for ostomy patient management: Seongwoo Yang, Ji Won Park, Hyuk Hur, Min Jung Kim, Seung-Yong Jeong, Kyounghoon Park, Ik Yong Kim; Ann Coloproctol. 2024;40(1):36-43. Published online November 21, 2022; DOI: https://doi.org/10.3393/ac.2022.00360.0051

4,332 View
285 Download
2 Web of Science
1 Citations

Purpose
The use of an ostomy for urination and defecation leads to reduced quality of life. Although many ostomy management strategies are needed, such strategies are often implemented by patients. Thus, there is a need for a home health care service platform that can be used in ostomy patient management.
Methods
We developed an ostomy patient management platform by identifying the needs of patients and medical staff through the Chronic Care Ostomy Self-Management Training Program in the United States and from studies conducted in Korea.
Results
The platform encompassed physical management, psychological management, maintenance of social function, spiritual stability, and home medical care. These components were implemented through monitoring, self-care guidance, and a community platform. For the monitoring function, patients entered their health status in a mobile application (app); the medical staff at the affiliated hospital then monitored the stoma status through a web interface.
Conclusion
Our platform allows medical staff to monitor ostomy patients through a web interface and help such patients to fully manage their ostomy at home using an app. We expect that the continued development of patient-oriented functions in our app will allow ostomy patients to experience quality-of-life improvements.

Citations

Citations to this article as recorded by

Lebensqualität von Stomapatienten
Michael S. Kasparek
coloproctology.2023; 45(4): 242. CrossRef

Malignant disease, Rectal cancer,Prognosis,Biomarker & risk factor

Can pretreatment platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict long-term oncologic outcomes after preoperative chemoradiation followed by surgery for locally advanced rectal cancer?: Sang Hyun An, Ik Yong Kim; Ann Coloproctol. 2022;38(3):253-261. Published online March 7, 2022; DOI: https://doi.org/10.3393/ac.2021.00633.0090

4,135 View
133 Download
11 Web of Science
13 Citations

Abstract PDF

Purpose
Systemic inflammation is associated with various malignancies, including colorectal cancer, as possible prognostic predictors. We aimed to evaluate the correlation of pretreatment the platelet-to-lymphocyte (PLR) and the neutrophil-to-lymphocyte (NLR) ratio with long-term oncologic outcomes and pathologic complete response (pCR) in locally ad vanced rectal cancer patients who received neoadjuvant concurrent chemoradiotherapy (CRT) followed by curative resection.
Methods
Between October 1996 and December 2015, 168 rectal cancer patients treated with preoperative CRT followed by surgery were enrolled. The set cut-off/mean PLR and NLR were 170 and 2.8. We analyzed the relationship between PLR, NLR, and the 5-year overall survival (OS), disease-free survival (DFS), and pCR rate.
Results
The 5-year OS rates were 75.9% and 59.8% in the highand low-PLR groups. The 5-year DFS rates were 62.9% and 50.8% in the high- and low-PLR groups, with no significant difference. In addition, the 5-year OS rates were 75.7% and 58.4%, and the 5-year DFS rates were 62.5% and 50.0% in the high- and low-NLR groups, respectively, both without any significant difference. Multivariate analysis showed only pretreatment PLR as an independent prognostic factor for OS (hazard ratio, 1.850; 95% confidence interval, 1.041–3.287; P=0.036), and both serologic markers were not independent prognostic factors for 5-year DFS.
Conclusion
Neither PLR nor NLR was associated with 5-year DFS nor pCR to neoadjuvant CRT. Only pretreatment PLR can be used in predicting OS in locally advanced rectal cancer patients who received neoadjuvant CRT followed by curative resection.

Citations

Citations to this article as recorded by

Effect of preoperative pan-immune-inflammation value on clinical and oncologic outcomes after colorectal cancer surgery: a retrospective study
Yun Ju Seo, Kyeong Eui Kim, Woon Kyung Jeong, Seong Kyu Baek, Sung Uk Bae
Annals of Surgical Treatment and Research.2024; 106(3): 169. CrossRef
Systemic Inflammatory Response Following Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in MSI-H/dMMR Rectal Cancer
Hyukjin Choi, Jin Ho Baek, An Na Seo, Su Yeon Park, Hye Jin Kim, Jun Seok Park, Gyu Seog Choi, Jong Gwang Kim, Byung Woog Kang
Chonnam Medical Journal.2024; 60(2): 105. CrossRef
Prognostic role of platelet-to-lymphocyte ratio in patients with rectal cancer undergoing resection: a systematic review and meta-analysis
Lijuan Ma, Fei Yang, Wentao Guo, Shufang Tang, Yarui Ling
Frontiers in Oncology.2024;[Epub] CrossRef
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) – A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group
Giuditta Chiloiro, Angela Romano, Silvia Mariani, Gabriella Macchia, Diana Giannarelli, Luciana Caravatta, Pierfrancesco Franco, Luca Boldrini, Alessandra Arcelli, Almalina Bacigalupo, Liliana Belgioia, Antonella Fontana, Elisa Meldolesi, Giampaolo Montes
Clinical and Translational Radiation Oncology.2023; 39: 100579. CrossRef
Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis
Giuseppe Portale, Patrizia Bartolotta, Danila Azzolina, Dario Gregori, Valentino Fiscon
Langenbeck's Archives of Surgery.2023;[Epub] CrossRef
Neutrophil-to-lymphocyte ratio predicts survival of patients with rectal cancer receiving neo-adjuvant chemoradiation followed by radical resection: a meta-analysis
Giuseppe Colloca, Antonella Venturino, Domenico Guarneri
Expert Review of Anticancer Therapy.2023; 23(4): 421. CrossRef
Prognostic prediction of colorectal cancer using the C-reactive protein to albumin ratio: the importance of inflammatory biomarkers and their association with long-term outcomes
Chul Seung Lee
Annals of Coloproctology.2023; 39(4): 287. CrossRef
Impact of Postoperative Naples Prognostic Score to Predict Survival in Patients with Stage II–III Colorectal Cancer
Su Hyeong Park, Hye Seung Woo, In Kyung Hong, Eun Jung Park
Cancers.2023; 15(20): 5098. CrossRef
Body composition parameters combined with blood biomarkers and magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Jianguo Yang, Qican Deng, Zhenzhou Chen, Yajun Chen, Zhongxue Fu
Frontiers in Oncology.2023;[Epub] CrossRef
Inflammatory Response Markers as Predictors of Colorectal Cancer Prognosis
Minsung Kim, Il Tae Son, Bo Young Oh
The Ewha Medical Journal.2023;[Epub] CrossRef
How Can We Improve the Tumor Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer?
Jeonghee Han
The Ewha Medical Journal.2023;[Epub] CrossRef
Neoadjuvant chemoradiotherapy determines the prognostic impact of anastomotic leakage in advanced rectal cancer
Bo Young Oh, Yoon Ah Park, Jung Wook Huh, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee
Annals of Surgical Treatment and Research.2022; 103(4): 235. CrossRef
Study on the Relationship between NEUT, NLR, PLR and the Severity of Coronary Artery Disease in Patients with ACS
延春蒋
Advances in Clinical Medicine.2022; 12(11): 9836. CrossRef

Malignant disease, Rectal cancer, Functional outcomes

Validation of Korean Version of Low Anterior Resection Syndrome Score Questionnaire: Chang Woo Kim, Woon Kyung Jeong, Gyung Mo Son, Ik Yong Kim, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park, Suk-Hwan Lee; Ann Coloproctol. 2020;36(2):83-87. Published online February 11, 2020; DOI: https://doi.org/10.3393/ac.2019.08.01

5,187 View
205 Download
18 Web of Science
17 Citations

Abstract PDF

Purpose
Patients who undergo radical surgery for rectal cancer often experience low anterior resection syndrome (LARS). Symptoms of this syndrome include frequent bowel movements, gas incontinence, fecal incontinence, fragmentation, and urgency. The aim of this study was to investigate the convergent validity, discriminative validity, and reliability of the Korean version of the LARS score questionnaire.
Methods
The English LARS score questionnaire was translated into Korean using the forward-and-back translation method. A total of 146 patients who underwent radical surgery for rectal cancer answered the Korean version of the LARS score questionnaire including an anchor question assessing the impact of bowel function. Participants answered the questionnaire once more after 2 weeks.
Results
The Korean LARS score questionnaire showed high convergent validity in terms of high correlation between the LARS score and quality of life (perfect fit 55.5% vs. moderate fit 37.6% vs. no fit 6.8%, respectively; P < 0.001). The LARS score also showed good discriminative validity between groups of patients differing by sex (29 for males vs. 25 for females; P = 0.014), tumor level (29 for ≤8 cm vs. 24 for >8 cm; P = 0.021), and radiotherapy (32 for yes vs. 24 for no; P = 0.001). The LARS score also demonstrated high reliability at test-retest with no difference between scores at the first and second tests (intraclass correlation coefficient: Q1 = 0.932; Q2 = 0.909, Q3 = 0.944, Q4 = 0.931, and Q5 = 0.942; P < 0.001, respectively).
Conclusion
The Korean version of the LARS score questionnaire has proven to be a valid and reliable tool for measuring LARS in Korean patients with rectal cancer.

Citations

Citations to this article as recorded by

Bowel dysfunction and lower urinary tract symptoms on quality of life after sphincter-preserving surgery for rectal cancer: A cross-sectional study
Hyekyung Kim, Hyedan Kim, Ok-Hee Cho
European Journal of Oncology Nursing.2024; 69: 102524. CrossRef
Effectiveness of personalized treatment stage-adjusted digital therapeutics in colorectal cancer: a randomized controlled trial
Inah Kim, Ji Young Lim, Sun Woo Kim, Dong Wook Shin, Hee Cheol Kim, Yoon Ah Park, Yoon Suk Lee, Jung-Myun Kwak, Seok Ho Kang, Ji Youl Lee, Ji Hye Hwang
BMC Cancer.2023;[Epub] CrossRef
Low anterior resection syndrome
Seung‐Bum Ryoo
Annals of Gastroenterological Surgery.2023; 7(5): 719. CrossRef
Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial
Min Jung Kim, Dae Won Lee, Hyun-Cheol Kang, Ji Won Park, Seung-Bum Ryoo, Sae-Won Han, Kyung Su Kim, Eui Kyu Chie, Jae Hwan Oh, Woon Kyung Jeong, Byoung Hyuck Kim, Eun Mi Nam, Seung-Yong Jeong
BMC Cancer.2023;[Epub] CrossRef
Validation of low anterior resection syndrome score in Brazil with Portuguese
Kelly C.L.R. Buzatti, Andy Petroianu, Søren Laurberg, Rodrigo G. Silva, Beatriz D.S. Rodrigues, Peter Christensen, Antonio Lacerda-Filho, Therese Juul
Annals of Coloproctology.2023; 39(5): 402. CrossRef
Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial)
Min Kyu Kang, Soo Yeun Park, Jun Seok Park, Hye Jin Kim, Jong Gwang Kim, Byung Woog Kang, Jin Ho Baek, Seung Hyun Cho, An Na Seo, Duck-Woo Kim, Jin Kim, Se Jin Baek, Ji Hoon Kim, Ji Yeon Kim, Gi Won Ha, Eun Jung Park, In Ja Park, Chang Hyun Kim, Hyun Kang
BMC Cancer.2023;[Epub] CrossRef
Clinical Implication of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
In Ja Park
The Ewha Medical Journal.2022; 45(1): 3. CrossRef
Low Anterior Resection Syndrome: Pathophysiology, Risk Factors, and Current Management
Seung Mi Yeo, Gyung Mo Son
The Ewha Medical Journal.2022;[Epub] CrossRef
Validation of the Vietnamese version of the low anterior resection syndrome score questionnaire
Tuong-Anh Mai-Phan, Vu Quang Pham
Annals of Coloproctology.2022;[Epub] CrossRef
Analgesic effect of structured anal skin care for perianal dermatitis after low anterior resection in the rectal cancer patients: prospective, single-center, open-label, therapeutic confirmatory, randomized clinical trial
Gyung Mo Son, In Young Lee, Mi Sook Yun, Jung-Hea Youn, Hong Min An, Kyung Hee Kim, Seung Mi Yeo, Bokyung Ku, Myeong Suk Kwon, Kun Hyung Kim
Annals of Surgical Treatment and Research.2022; 103(6): 360. CrossRef
Two dominant patterns of low anterior resection syndrome and their effects on patients’ quality of life
Min Jung Kim, Ji Won Park, Mi Ae Lee, Han-Ki Lim, Yoon-Hye Kwon, Seung-Bum Ryoo, Kyu Joo Park, Seung-Yong Jeong
Scientific Reports.2021;[Epub] CrossRef
Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer
S -B Ryoo, J W Park, D W Lee, M A Lee, Y -H Kwon, M J Kim, S H Moon, S -Y Jeong, K J Park
British Journal of Surgery.2021; 108(6): 644. CrossRef
The incidence and risk factors of low anterior resection syndrome (LARS) after sphincter-preserving surgery of rectal cancer: a systematic review and meta-analysis
Rui Sun, Ziyi Dai, Yin Zhang, Junyang Lu, Yuelun Zhang, Yi Xiao
Supportive Care in Cancer.2021; 29(12): 7249. CrossRef
Defining low anterior resection syndrome (LARS): Scoring tools and patient-reported outcomes
Dr Rebekka Troller, Dr Jeremy Meyer, Mr Justin Davies
Seminars in Colon and Rectal Surgery.2021; 32(4): 100847. CrossRef
The Effect of Anastomotic Leakage on the Incidence and Severity of Low Anterior Resection Syndrome in Patients Undergoing Proctectomy: A Propensity Score Matching Analysis
Sungjin Kim, Sung Il Kang, So Hyun Kim, Jae-Hwang Kim
Annals of Coloproctology.2021; 37(5): 281. CrossRef
Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes
Guglielmo Niccolò Piozzi, Seon Hahn Kim
Annals of Coloproctology.2021; 37(6): 351. CrossRef
Functional outcomes after sphincter-preserving surgeries for low-lying rectal cancer: A review
Eun Jung Park, Seung Hyuk Baik
Precision and Future Medicine.2021; 5(4): 164. CrossRef

Anaphase-Promoting Complex 7 is a Prognostic Factor in Human Colorectal Cancer: Ik Yong Kim, Hye Yeon Kwon, Kwang Hwa Park, Dae Sung Kim; Ann Coloproctol. 2017;33(4):139-145. Published online August 31, 2017; DOI: https://doi.org/10.3393/ac.2017.33.4.139

3,989 View
59 Download
8 Web of Science
8 Citations

Abstract PDF

Purpose

The anaphase-promoting complex (APC) is a multiprotein complex with E3 ubiquitin ligase activity and is required for ubiquitination of securin and cyclin-B. Several APC-targeting molecules are reported to be oncogenes. Dysregulation of APC may be associated with tumorigenesis. This study examines the relationship between APC expression and clinicopathological factors and evaluates the possibility of an aberrant APC function in colorectal carcinomas (CRCs).

Methods

To determine whether the loss of APC7 expression is related to tumorigenesis, we used tissue micro-arrays in 114 resected CRCs to scrutinize the expressions of APC7 and Ki-67 immunohistochemistry and to find relations with clinocopathologic parameters. The expression of APC7 was defined as positive for summed scores of staining intensities from 0 to 3+.

Results

Forty-four cases (67.7%) of colon cancer and 38 cases (77.6%) of rectal cancer showed immunopositive reactions to APC. The grade of APC expression was not statistically correlated with tumor location, age, T or TNM stage, or differentiation. However, the expression of APC did correlate with the expression of Ki-67 and to the tumor recurrent. Higher APC expression showed the better 5-year overall survival rate in 74% of grades 2, 3 groups (high expression) than 57% of grades 0, 1 groups (lower expression) respectively (P = 0.042).

Conclusion

Positive APC expression may be a good prognostic factor for patients with CRC, and the loss of APC expression in tumor tissue may be related with the risk for recurrence and a poor survival rate compared to high APC expression. Further study of APC in controlling the cell cycle as aberrant function in CRC is needed.

Citations

Citations to this article as recorded by

Microbiota as the unifying factor behind the hallmarks of cancer
Iva Benešová, Ľudmila Křížová, Miloslav Kverka
Journal of Cancer Research and Clinical Oncology.2023; 149(15): 14429. CrossRef
Upregulation of anaphase promoting complex (APC) 7 as a prognostic marker for esophageal squamous cell carcinoma: A hospital based study
Eyashin Ali, Manash Jyoti Kalita, Simanta Kalita, Jayasree Talukdar, Ankur Jyoti Deka, Jasmin Sultana, Bikash Narayan Choudhury, Munindra Narayan Baruah, Sahana Bhattacharjee, Subhash Medhi
Heliyon.2022; 8(6): e09722. CrossRef
Gatekeepers of the Gut: The Roles of Proteasomes at the Gastrointestinal Barrier
Gayatree Mohapatra, Avital Eisenberg-Lerner, Yifat Merbl
Biomolecules.2021; 11(7): 989. CrossRef
Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data
Giuseppe Agapito, Mario Cannataro
BMC Bioinformatics.2021;[Epub] CrossRef
Extensive loss of cell-cycle and DNA repair genes in an ancient lineage of bipolar budding yeasts
Jacob L. Steenwyk, Dana A. Opulente, Jacek Kominek, Xing-Xing Shen, Xiaofan Zhou, Abigail L. Labella, Noah P. Bradley, Brandt F. Eichman, Neža Čadež, Diego Libkind, Jeremy DeVirgilio, Amanda Beth Hulfachor, Cletus P. Kurtzman, Chris Todd Hittinger, Antoni
PLOS Biology.2019; 17(5): e3000255. CrossRef
Identification of Novel Molecular Network Expression in Acute Myocardial Infarction
Marwa Matboli, Ayman E. Shafei, Sara H.A. Agwa, Sherif Sammir Elzahy, Ahmed K. Anwar, Amr R. Mansour, Ahmed I. Gaber, Ali E.A. Said, Paula Lwis, Marwa Hamdy
Current Genomics.2019; 20(5): 340. CrossRef
Activating the Anaphase Promoting Complex to Enhance Genomic Stability and Prolong Lifespan
Troy A. A. Harkness
International Journal of Molecular Sciences.2018; 19(7): 1888. CrossRef
What is the Meaning of Anaphase-Promoting Complex 7 in Malignant Neoplasms?
Weon-Young Chang
Annals of Coloproctology.2017; 33(4): 123. CrossRef

Editorials

Minimally Invasive Interval Appendectomy for Perforated Appendicitis With a Periappendiceal Abscess: Ik Yong Kim; Ann Coloproctol. 2016;32(3):88-89. Published online June 30, 2016; DOI: https://doi.org/10.3393/ac.2016.32.3.88

3,661 View
67 Download
2 Web of Science
2 Citations

PDF

Citations

Citations to this article as recorded by

Acute Appendicitis with Appendicolith and its Complication and Management: A Case Report
Maya Ann Francis, Resheek Nerella, Deepa Treesa Francis, Rohan Raj, Ahmer Zain, Sana Augustine, Niyaz A Jamil
Cureus.2023;[Epub] CrossRef
Retained fecalith following laparoscopic appendectomy
Yegi Sandy Kim, Joseph Cherng Kong, Evan Williams, Satish K. Warrier
Clinical Case Reports.2021; 9(3): 1651. CrossRef

Impact of Microsatellite Instability in Signet-Ring Cell and Mucinous Components in Patients With Colorectal Carcinoma: Ik Yong Kim; Ann Coloproctol. 2016;32(2):45-46. Published online April 30, 2016; DOI: https://doi.org/10.3393/ac.2016.32.2.45

3,092 View
39 Download
1 Web of Science
2 Citations

PDF

Citations

Citations to this article as recorded by

Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort
Marion Allart, Florence Leroy, Stephano Kim, David Sefrioui, Mihane Nayeri, Aziz Zaanan, Benoit Rousseau, Meher Ben Abdelghani, Christelle de la Fouchardière, Wulfran Cacheux, Romain Legros, Samy Louafi, David Tougeron, Olivier Bouché, Nadim Fares, Guilla
Digestive and Liver Disease.2022; 54(3): 391. CrossRef
Cáncer de colon en Colombia, fenotipo molecular: tamizaje para síndromes con agregación familiar
Mabel Elena Bohórquez L, Ángel Alexandro Criollo R, Luis Carvajal Carmona, María Magdalena Echeverry de Polanco
Revista de la Asociación Colombiana de Ciencias Biológicas.2019; : 87. CrossRef

Biofeedback Therapy After Sphincter-Preservation Surgery for the Treatment of Rectal Cancer: Ik Yong Kim; Ann Coloproctol. 2015;31(4):119-120. Published online August 31, 2015; DOI: https://doi.org/10.3393/ac.2015.31.4.119

3,198 View
38 Download

PDF

Preoperative Staging With Positron Emission Tomography in Patients With Colorectal Cancer: Young Wan Kim, Ik Yong Kim; Ann Coloproctol. 2014;30(6):247-247. Published online December 31, 2014; DOI: https://doi.org/10.3393/ac.2014.30.6.247

2,698 View
28 Download

PDF

Sexual Function After a Proctectomy for the Treatment of Rectal Cancer: Young Wan Kim, Ik Yong Kim; Ann Coloproctol. 2014;30(5):205-205. Published online October 28, 2014; DOI: https://doi.org/10.3393/ac.2014.30.5.205

2,717 View
28 Download

PDF

The New Stapler Device Is Good, But Needs More Evaluation: Young Wan Kim, Ik Yong Kim; Ann Coloproctol. 2014;30(2):59-59. Published online April 25, 2014; DOI: https://doi.org/10.3393/ac.2014.30.2.59

2,539 View
34 Download
1 Web of Science

PDF

Review

The Role of Surgery for Asymptomatic Primary Tumors in Unresectable Stage IV Colorectal Cancer: Young Wan Kim, Ik Yong Kim; Ann Coloproctol. 2013;29(2):44-54. Published online April 30, 2013; DOI: https://doi.org/10.3393/ac.2013.29.2.44

4,304 View
36 Download
28 Citations

Abstract PDF

There are still debates regarding the appropriate primary treatment policy for asymptomatic primary colorectal lesions in cases of unresectable metastatic colorectal cancer. Even though there are patients with asymptomatic primary tumors when starting chemotherapy, those patients may still undergo surgery due to complications related to primary tumors in the middle of chemotherapy; therefore, controversy exists regarding surgical resection of primary colorectal lesions in cases where symptoms are absent when making a diagnosis. Thus, based on the published literature, we discuss opinions that prefer first-line surgery for primary tumors as well as opinions favoring first-line chemotherapy for treating unresectable synchronous metastatic colorectal cancer. Although the upfront chemotherapy including targeted agents is suggested as an effective treatment in recent years, the first line surgery has been a preferred treatment for decades. The first line surgery is beneficial to prolong the survival duration given the retrospective analysis of randomized trial data. So far, no prospective comparison study has only focused on the first-line treatment modality; thus, future clinical studies focusing on the survival duration and the quality of life should be performed as soon as possible. Furthermore, at this point, multidisciplinary team approaches would be helpful in finding the appropriate therapy. Regardless of symptoms, the performance status and the tumor burden should be taken into consideration as well. In case of surgical resection, minimally invasive surgery, such as laparoscopic surgery, is recommended.

Citations

Citations to this article as recorded by

Randomized non-inferiority single-center prospective trial of malignant colonic obstruction therapy with Self-expandable metal stent (SEMS) endoscopic placement or stoma formation
I.E. Gorovaia, P.V. Tsarkov, P.V. Pavlov, I.A. Tulina, V.I. Zhurkovskiy
Endoscopic Surgery.2024; 30(2): 5. CrossRef
Fístula anastomótica y reingreso no programado al quirófano en cirugía oncológica colorrectal electiva: experiencia de un centro de alta complejidad
Diego Téllez, Daniela Yucuma, María Díaz, Saúl-Javier Rúgeles, Luis Jorge Lombana
Revista Mexicana de Coloproctología Enfermedades del Ano, Recto y Colon.2024; 20(1): 19. CrossRef
Palliative procedures for advanced obstructive colorectal cancer: a systematic review and meta-analysis
Bingqing Ma, Tianxing Ren, Chengjun Cai, Biao Chen, Jinxiang Zhang
International Journal of Colorectal Disease.2024;[Epub] CrossRef
Impact of primary tumor resection on the survival of patients with unresectable colon cancer liver metastasis at different colonic subsites: a propensity score matching analysis
Jiefeng Zhao, Jinfeng Zhu, Chao Huang, Rongfa Yuan, Zhengming Zhu
Acta Chirurgica Belgica.2023; 123(2): 132. CrossRef
Prognosis of patients with unresectable stage IV Colon cancer undergoing primary tumor resection: A multicenter study of minimally symptomatic or asymptomatic primary tumor
Man Fung Ho, Victoria Cindy Lai, Dennis Chung Kei Ng, Simon Siu Man Ng
Asian Journal of Surgery.2023; 46(9): 3710. CrossRef
Asymptomatic Primary Tumor Resection in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Yefei Shu, Ling Xu, Wei Yang, Xiaofeng Xu, Song Zheng
Frontiers in Oncology.2022;[Epub] CrossRef
Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer
Sanghyun An, Hongjin Shim, Kwangmin Kim, Bora Kim, Hui-Jae Bang, Hyejin Do, Hyang-Rae Lee, Youngwan Kim
Annals of Coloproctology.2022; 38(2): 97. CrossRef
Stenting as a bridge to surgery for obstructed stage IV colorectal cancers – long‐term outcomes of a 10‐year study
Aik Yong Chok, Hui Jun Lim, Weng Kit Lye, Lasitha B Samarakoon, Jiwei Guo, Choong Leong Tang, Ronnie Mathew
Asian Journal of Endoscopic Surgery.2020; 13(3): 343. CrossRef
Frequency of unplanned surgery in patients with stage IV colorectal cancer receiving palliative chemotherapy with an intact primary: An analysis of SEER‐Medicare
Patrick D. Lorimer, Benjamin M. Motz, Russell C. Kirks, Yimei Han, James T. Symanowski, Jimmy J. Hwang, Jonathan C. Salo, Joshua S. Hill
Journal of Surgical Oncology.2019; 120(3): 407. CrossRef
The American Society of Anesthesiologists score influences on postoperative complications and total hospital charges after laparoscopic colorectal cancer surgery
Jae-Hyun Park, Dong-Hyun Kim, Bo-Ra Kim, Young-Wan Kim
Medicine.2018; 97(18): e0653. CrossRef
Identification of factors predictive of postoperative morbidity and short-term mortality in older patients after colorectal carcinoma resection: A single-center retrospective study
Teresa Schreckenbach, Matthias Valentin Zeller, Hanan El Youzouri, Wolf Otto Bechstein, Guido Woeste
Journal of Geriatric Oncology.2018; 9(6): 649. CrossRef
The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor
Qian-Kun Xie, Ping Chen, Wan-Ming Hu, Peng Sun, Wen-Zhuo He, Chang Jiang, Peng-Fei Kong, Shou-Sheng Liu, Hai-Tian Chen, Yuan-Zhong Yang, Dan Wang, Lin Yang, Liang-Ping Xia
Journal of Translational Medicine.2018;[Epub] CrossRef
Comparison of the Short-Term Outcomes of Laparoscopic and Open Resections for Colorectal Cancer in Patients with a History of Prior Median Laparotomy
Young Wan Kim, Ik Yong Kim
Indian Journal of Surgery.2017; 79(6): 527. CrossRef
A Novel Derivation Predicting Survival After Primary Tumor Resection in Stage IV Colorectal Cancer: Validation of a Prognostic Scoring Model and an Online Calculator to Provide Individualized Survival Estimation
Winson Jianhong Tan, Sreemanee Raaj Dorajoo, Madeline Yen Min Chee, Wah Siew Tan, Fung Joon Foo, Choong Leong Tang, Min Hoe Chew
Diseases of the Colon & Rectum.2017; 60(9): 895. CrossRef
Comparative effectiveness of chemotherapy vs resection of the primary tumour as the initial treatment in older patients with Stage IV colorectal cancer
H. B. Mehta, G. M. Vargas, D. Adhikari, F. Dimou, T. S. Riall
Colorectal Disease.2017;[Epub] CrossRef
Primary tumor resection in stage IV unresectable colorectal cancer: what has changed?
Michał Pędziwiatr, Magdalena Mizera, Jan Witowski, Piotr Major, Grzegorz Torbicz, Natalia Gajewska, Andrzej Budzyński
Medical Oncology.2017;[Epub] CrossRef
The influence of local therapy on the survival of patients with metastatic rectal cancer: a population-based, propensity-matched study
Chi-Hao Zhang, Yuan-Bo Pan, Qing-Wei Zhang, Ou-Min Shi, Lei Zheng, Liang Gui, Meng Luo
Journal of Cancer Research and Clinical Oncology.2017; 143(9): 1891. CrossRef
Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis
Rong-xin Zhang, Wen-juan Ma, Yu-ting Gu, Tian-qi Zhang, Zhi-mei Huang, Zhen-hai Lu, Yang-kui Gu
World Journal of Surgical Oncology.2017;[Epub] CrossRef
The impact of delayed commencement of adjuvant chemotherapy (eight or more weeks) on survival in stage II and III colon cancer: a national population-based cohort study
Young Wan Kim, Eun Hee Choi, Bo Ra Kim, Woo-Ah Ko, Yeong-Mee Do, Ik Yong Kim
Oncotarget.2017; 8(45): 80061. CrossRef
Lymph node status as a prognostic factor after palliative resection of primary tumor for patients with metastatic colorectal cancer
Qingguo Li, Changjian Wang, Yaqi Li, Xinxiang Li, Ye Xu, Guoxiang Cai, Peng Lian, Sanjun Cai
Oncotarget.2017; 8(29): 48333. CrossRef
Long-term outcomes of palliation for unresectable colorectal cancer obstruction in patients with good performance status: endoscopic stent versus surgery
Hyo Jun Ahn, Sang Woo Kim, Sung Won Lee, Soon Wook Lee, Chul-Hyun Lim, Jin Su Kim, Yu Kyung Cho, Jae Myung Park, In Seok Lee, Myung-Gyu Choi
Surgical Endoscopy.2016; 30(11): 4765. CrossRef
Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer
Hugh Colvin, Naohiro Nishida, Masamitsu Konno, Naotsugu Haraguchi, Hidekazu Takahashi, Junichi Nishimura, Taishi Hata, Koichi Kawamoto, Ayumu Asai, Kenta Tsunekuni, Jun Koseki, Tsunekazu Mizushima, Taroh Satoh, Yuichiro Doki, Masaki Mori, Hideshi Ishii
Scientific Reports.2016;[Epub] CrossRef
A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis
S. R. Dorajoo, W. J. H. Tan, S. X. Koo, W. S. Tan, M. H. Chew, C. L. Tang, H. L. Wee, C. W. Yap
International Journal of Colorectal Disease.2016; 31(2): 235. CrossRef
Factors Affecting Use and Delay (≥8 Weeks) of Adjuvant Chemotherapy after Colorectal Cancer Surgery and the Impact of Chemotherapy-Use and Delay on Oncologic Outcomes
Ik Yong Kim, Bo Ra Kim, Young Wan Kim, Ramon Andrade de Mello
PLOS ONE.2015; 10(9): e0138720. CrossRef
The Role of Palliative Resection for Asymptomatic Primary Tumor in Patients With Unresectable Stage IV Colorectal Cancer
Jung-A Yun, Jung Wook Huh, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun
Diseases of the Colon & Rectum.2014; 57(9): 1049. CrossRef
A Meta-Analysis to Determine the Effect of Primary Tumor Resection for Stage IV Colorectal Cancer with Unresectable Metastases on Patient Survival
Cillian Clancy, John P. Burke, Mitchel Barry, Matthew F. Kalady, J. Calvin Coffey
Annals of Surgical Oncology.2014; 21(12): 3900. CrossRef
Association Between Palliative Resection of the Primary Tumor and Overall Survival in a Population-Based Cohort of Metastatic Colorectal Cancer Patients
Gillian Gresham, Daniel J. Renouf, Matthew Chan, Hagen F. Kennecke, Howard J. Lim, Carl Brown, Winson Y. Cheung
Annals of Surgical Oncology.2014; 21(12): 3917. CrossRef
Risk factors for the requirement of surgical or endoscopic interventions during chemotherapy in patients with uncomplicated colorectal cancer and unresectable synchronous metastases
Jung-A Yun, Yoonah Park, Jung Wook Huh, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun
Journal of Surgical Oncology.2014; 110(7): 839. CrossRef

Editorial

Factors Affecting the Outcome of a Pulmonary Resection for Metastatic Colorectal Cancer: Efficacy and Pitfalls: Ik Yong Kim; J Korean Soc Coloproctol. 2010;26(5):309-310. Published online October 31, 2010; DOI: https://doi.org/10.3393/jksc.2010.26.5.309

2,420 View
26 Download

PDF

First
Prev
Page of 1
Next
Last

Search